Literature DB >> 31726112

Development and validation of nucleic acid tests to diagnose Aleutian mink disease virus.

Jenni Virtanen1, Kirsi Aaltonen2, Olli Vapalahti2, Tarja Sironen2.   

Abstract

Aleutian disease (AD), caused by Aleutian mink disease virus (AMDV), causes significant welfare problems to mink, and financial losses to the farmers. As there is no vaccine or treatment available, reliable diagnostics is important for disease control. Here, we set up a probe-based real-time PCR (NS1-probe-PCR) to detect all strains of AMDV. PCR was validated and compared to two other real-time PCR methods (pan-AMDV- and pan-AMDO-PCR) currently used for AMDV diagnostics in Finland. The NS1-probe-PCR had a similar detection limit of 20 copies/reaction based on plasmid dilution series, and similar or better diagnostic sensitivity, when evaluated using spleen samples from mink, and stool samples from mink and foxes. None of the three PCR tests cross-reacted with other parvoviruses. The NS1-probe-PCR also showed a significantly higher specificity than the pan-AMDO-PCR with spleen samples and the best specificity with stool samples. Furthermore, it produced the results more rapidly than the other two PCRs making it a promising tool for both diagnostic and research purposes.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AMDV; Diagnostics; qPCR

Mesh:

Year:  2019        PMID: 31726112     DOI: 10.1016/j.jviromet.2019.113776

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  2 in total

1.  Assessment of Aleutian mink disease virus (AMDV) prevalence in feral American mink in Iceland. Case study of a pending epizootiological concern in Europe.

Authors:  Remigiusz Panicz; Piotr Eljasik; Jakub Skorupski; Przemysław Śmietana; Róbert A Stefánsson; Menja von Schmalensee; Magdalena Szenejko
Journal:  PeerJ       Date:  2021-09-17       Impact factor: 2.984

Review 2.  AMDV Vaccine: Challenges and Perspectives.

Authors:  Nathan M Markarian; Levon Abrahamyan
Journal:  Viruses       Date:  2021-09-14       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.